At CD BioGlyco, we leverage over specialized expertise in glycobiology to offer a comprehensive glycomic characterization service. Our service is meticulously designed to elucidate the precise structures and profiles of glycans present in various biological samples, providing researchers and pharmaceutical developers with critical insights into glycan function, biomarker identification, and drug development.
Carbohydrates are involved in most biological processes in cells, and any alterations in glycan structure or composition may be a cause or consequential attribute of biochemical imbalance. Therefore in current glycobiology research, it is increasingly significant to understand the structural details of biologically important polysaccharides. During the past years, sophisticated mass spectrometry techniques and instrumentation have been developed rapidly in the biomedical field. While these developments have been driven primarily by the demand in the fields of protein science and proteomic research, contemporary glycobiology has also benefited from these developments.
Characterization of the glycome is a key part of understanding the biological basis of health and disease. A number of technologies and methods have been developed to help decipher glycosylation and elucidate glycomic changes. At present, novel mass analyzers and tandem mass spectrometry techniques are now being used to determine the sequence, linkage, chain branching, and other aspects of oligosaccharide structures with unprecedented sensitivity and mass resolution.
We employ high-performance liquid chromatography (HPLC) for efficient separation of glycan species, often coupled with fluorescence detection for enhanced sensitivity. Mass spectrometry (MS), including techniques like Matrix-assisted laser desorption/ionization time-of-flight MS (MALDI-TOF MS), electrospray ionization tandem-MS (ESI-MS/MS), and LC-MS/MS, is central to our approach, enabling precise mass determination, structural elucidation, and quantitative profiling of glycans.
CD BioGlyco has made significant progress in the development of powerful structural tools to probe even the most complex structural properties of various intracellular and intercellular signaling and regulation. We offer a wide range of services to our clients in the field of glycomics, including glycan profiling, glycan sequencing, and glycan structure analysis.
Our glycomic characterization service follows a meticulously designed, multi-stage workflow to ensure accurate, reproducible, and comprehensive analysis of glycans from diverse biological samples. Our service process is as follows:
Specific protein denaturation, lipid removal, and nucleic acid extraction protocols are employed to ensure optimal glycan accessibility and purity.
N-glycans are enzymatically released using PNGase F, and O-glycans are released using reductive β-elimination or non-reducing chemical methods. Derivatization or permethylation with fluorescent markers is then performed to enhance detection sensitivity.
High-performance liquid chromatography (HPLC) is used to separate complex glycan mixtures, while liquid chromatography-mass spectrometry (LC-MS) is used to isolate and detect individual glycan species.
Matrix-assisted laser desorption ionization time-of-flight MS (MALDI-TOF-MS) is used to precisely measure glycan masses, and tandem MS (MS/MS) analyzes monosaccharide composition, linkage types, and branching patterns.
We utilize specialized software and databases to interpret and validate glycan profiles and structures and provide a comprehensive report detailing the experimental procedures, raw data, and processed results.
Journal: Molecules
IF: 4.6
Published: 2022
Results: This article focuses on the development and application of an innovative analytical platform. This platform combines MS with glycomics and glycoproteomics approaches. This study aims to utilize an advanced integrated system to functionally characterize the glycosylation inhibitor pictilisib, encompassing glycomics analysis, proteomics analysis, and in vitro experiments. This study highlights the application of MS in identifying potential glycosylation inhibitors and evaluating their effects on cell surface glycoprotein abundance and protein interactions.
CD BioGlyco is your trusted partner in glycobiology, offering a comprehensive glycomic characterization service that provides unparalleled insights into the intricate world of glycans. From precise profiling and sequencing to detailed structural elucidation, our advanced technological platforms and expert scientific team are dedicated to supporting your research and development endeavors across diverse applications. Please feel free to contact us to discuss your specific project needs.
To further support your research and development goals, CD BioGlyco offers a suite of complementary services and specialized options related to glycomics:
Reference